Cargando…

Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension

BACKGROUND: Previous clinical trials with birch pollen subcutaneous immunotherapy have been conducted over a 1‐ to 2‐year treatment period and involved mostly a single geographic location. OBJECTIVE: This study (EudraCT‐Number: 2005‐000025‐35) intended to evaluate the effect of subcutaneous immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worm, Margitta, Rak, Sabina, Samoliński, Boleslaw, Antila, Jukka, Höiby, Ann‐Sofi, Kruse, Brigitte, Lipiec, Agnieszka, Rudert, Michael, Valovirta, Erkka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849700/ https://www.ncbi.nlm.nih.gov/pubmed/30570787 http://dx.doi.org/10.1111/cea.13331

Ejemplares similares

Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
por: Bożek, Andrzej, et al.
Publicado: (2017)

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023)

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy
por: Worm, M., et al.
Publicado: (2018)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
por: Sager, Angelika, et al.
Publicado: (2012)

10 Seasonal Versus Symptom-based Evaluation of a Depigmented Grass-Birch Allergoid
por: Pfaar, Oliver, et al.
Publicado: (2012)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
por: Worm, Margitta, et al.
Publicado: (2014)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid
por: Gawlik, Radoslaw, et al.
Publicado: (2016)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

Birch pollen—The unpleasant herald of spring
por: Raith, Marianne, et al.
Publicado: (2023)

Prevalence of allergic rhinitis and asthma in Poland in relation to pollen counts
por: Lipiec, Agnieszka, et al.
Publicado: (2019)

Prediction of the birch pollen season characteristics in Cracow, Poland using an 18-year data series
por: Dorota, Myszkowska
Publicado: (2012)

Extension of WRF-Chem for birch pollen modelling—a case study for Poland
por: Werner, Małgorzata, et al.
Publicado: (2020)

Quantitative DNA Analyses for Airborne Birch Pollen
por: Müller-Germann, Isabell, et al.
Publicado: (2015)

Chinese Birch Pollen Allergy and Immunotherapy in Mice
por: Xie, Zhijuan, et al.
Publicado: (2019)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
por: Roger, Albert, et al.
Publicado: (2014)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Exposure to grass pollen – but not birch pollen – affects lung function in Swedish children
por: Gruzieva, O., et al.
Publicado: (2015)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Valovirta, Erkka
Publicado: (2012)

Identification of birch pollen species using FTIR spectroscopy
por: Depciuch, Joanna, et al.
Publicado: (2018)

Is Pollen Production of Birch Controlled by Genetics and Local Conditions?
por: Ranpal, Surendra, et al.
Publicado: (2022)

PD15 - MP29-02 effectively relieves both nasal and ocular symptoms in adolescents aged 12-17 years: results from a meta-analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials
por: Valovirta, Erkka, et al.
Publicado: (2014)

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
por: Reithofer, Manuel, et al.
Publicado: (2023)

The Influence of Recombinant Production on the Immunologic Behavior of Birch Pollen Isoallergens
por: Wallner, Michael, et al.
Publicado: (2009)

Multi-Approach Analysis for the Identification of Proteases within Birch Pollen
por: McKenna, Olivia E., et al.
Publicado: (2017)

Survey on the impact of comorbid allergic rhinitis in patients with asthma
por: Valovirta, Erkka, et al.
Publicado: (2006)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Glutathione-S-Transferase: A Minor Allergen in Birch Pollen due to Limited Release from Hydrated Pollen
por: Deifl, Stephan, et al.
Publicado: (2014)

An assessment of cross reactivity with patients allergic to birch pollen using the immunoblotting
por: Zbikowska-Gotz, Magdalena, et al.
Publicado: (2011)

Anaphylaxis to topical Aloe vera in a birch pollen allergic child
por: Varga, Eva-Maria, et al.
Publicado: (2014)

High Environmental Ozone Levels Lead to Enhanced Allergenicity of Birch Pollen
por: Beck, Isabelle, et al.
Publicado: (2013)

Cross-Reactivity between Oak and Birch Pollens in Korean Tree Pollinosis
por: Jeong, Kyoung Yong, et al.
Publicado: (2016)

Comparative proteomics of common allergenic tree pollens of birch, alder, and hazel
por: Darnhofer, Barbara, et al.
Publicado: (2021)

Revealing the Chemical Composition of Birch Pollen Grains by Raman Spectroscopic Imaging
por: Stiebing, Clara, et al.
Publicado: (2022)

Structural Basis of the Immunological Cross-Reactivity between Kiwi and Birch Pollen
por: Zeindl, Ricarda, et al.
Publicado: (2023)

The History and Science of the Major Birch Pollen Allergen Bet v 1
por: Breiteneder, Heimo, et al.
Publicado: (2023)

Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen
por: Ishida, Waka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_on6b6ktutukvitb18mbun71tn0